 |  |
| BISNIS-27 | ||
| 572.940 | ||
| -9.8850 | -0.0170% | |
| COMPOSITE | ||
| 7,087.317 | ||
| -79.3600 | -0.0111% | |
| DBX | ||
| 1,607.849 | ||
| -9.9190 | -0.0061% | |
| ESGSKEHATI | ||
| 134.651 | ||
| -2.4280 | -0.0177% | |
| I-GRADE | ||
| 231.306 | ||
| -3.4500 | -0.0147% | |
| IDX30 | ||
| 466.838 | ||
| -7.5880 | -0.0160% | |
| IDX80 | ||
| 126.965 | ||
| -1.9000 | -0.0147% | |
| AUDRP | ||
| 10,310.300 | ||
| -10.9000 | -0.1056% | |
| EURRP | ||
| 17,080.200 | ||
| -22.4000 | -0.1310% | |
| JPYRP | ||
| 104.190 | ||
| -0.0400 | -0.0384% | |
| RP | ||
| 15,771.000 | ||
| -13.0000 | -0.0824% | |
| SINRP | ||
| 11,733.600 | ||
| 11.4000 | 0.0973% | |
Penelitian terhadap vaksin nasional COVID-19, Vaksin Merah Putih, terus berlanjut, salah satunya oleh tim peneliti Universitas Airlangga bersama PT Biotis Pharmaceutical Indonesia. Penelitian vaksin telah memasuki uji praklinis tahap II.
